Type Here to Get Search Results !

TruAlt Bioenergy Share Targets 2025-2026: Price Projections

Piyush Sharma 0
TruAlt Bioenergy: Upside Price Projections & Strategy (Oct 2025 - Sep 2026)
Quarter Projected Target (Rs.) Strong Buy Zone (Rs.) Profit Booking Zone (Rs.) Resistance Level (Rs.) Remarks
Q4 FY26 (Jan-Mar 2026) 700 - 730 500 - 520 680 - 730 750 Strong Buy on dips due to annual result expectations. Book profits near upper targets as stock may get overvalued.
Q1 FY27 (Apr-Jun 2026) 750 - 790 580 - 600 770 - 790 810 Momentum likely to continue post strong FY26 results. Partial profit booking advised.
Q2 FY27 (Jul-Sep 2026) 820 - 880 650 - 680 850 - 880 900 Potential for re-rating if growth sustains. Consider significant profit booking in this zone.
TruAlt Bioenergy: Downside Risk & Exit Strategy
Key Level Price (Rs.) Action Remarks
Breakout Level Above 530 Buy / Add Confirmation of bullish trend. Indicates strength to move towards higher targets.
Strong Support 470 - 450 Hold / Accumulate Critical demand zone. A bounceback is expected from here.
Breakdown Level Below 445 Caution / Partial Exit Weakness signal. High probability of falling further.
Strong Sell / Full Exit Below 400 Exit Position Fundamental story may be broken. Protect capital.
TruAlt Bioenergy: Support & Resistance Levels
Support Levels (Rs.) Resistance Levels (Rs.) Signal
470 - 450 (Major Support) 530 (Immediate Resistance) Accumulate at Support
445 (Breakdown Level) 600 - 620 (Medium-term) Watch for Breakdown
400 (Final Support) 750 - 790 (Strong Resistance) Exit if Broken

Pro Trading & Investment Tips

For Long-Term Investors:

  • Use the "Strong Buy Zone" from the table for Systematic Investment (SIP)
  • Hold for 2-3 years to benefit from the company's growth story
  • Ignore short-term noise and focus on quarterly results

For Short-Term Traders:

  • Trade between support (Rs. 470-450) and resistance levels
  • Breakout above Rs. 530 with volume is a strong buy signal
  • Use strict stop-loss below Rs. 445 to protect capital

Risk Management Strategy:

  • Never average a losing position below breakdown levels
  • Book partial profits at each target level
  • IPO allottees should use trailing stop-loss after listing

Expected FY26 Financial Performance

  • Revenue Growth: 35-45% (Total Income: ~Rs. 2,700 - 2,850 Cr)
  • PAT Growth: 40-50% (Net Profit: ~Rs. 205 - 220 Cr)
  • EBITDA Margin: Expected to improve to 17-18%
  • Key Monitorables: Debt reduction, margin expansion, and capacity utilization rates
  • Risk Factors: High valuation (P/E 29.01), Debt/Equity ratio of 2.02, execution risks
Disclaimer: This analysis is based on Avaialble company FY25 data and standard financial modeling techniques. The stock market is inherently volatile, and this should not be considered as direct financial advice. Always consult with a qualified financial advisor before making any investment decisions.
TruAlt Bioenergy Share Targets 2025
Indian Flag

Piyush Sharma

Qualifications: MBA (India), MBA (Australia), Master of Professional Accounting (Australia).

18+ years in the Indian stock market and running this website for 15+ years. Founder of PS International Group and Hamarijeet.com — popular for study-visa guidance, career help, government schemes, jobs and digital product updates.

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.

Top Post Ad